Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Review Article Volume 4 Issue 11

Challenges in Screening, Diagnosis and Management of Colorectal Cancers in Covid-19 Era

Sumit Kumar3, Vishal Kaundal2,Vandana Singh Kushwaha5, Shalini Verma1*, Muninder Negi1 and Nitin Gupta4

1Radiation Oncology Department, Dr RPGMC, Tanda, Himachal Pradesh, India
2Surgery Department, Dr RPGMC, Tanda, Himachal Pradesh, India
3Radiation Department, AIIMS, New Delhi, India
4Nuclear Medicine Department, Dr RPGMC, Tanda, Himachal Pradesh, India
5Radiation Oncology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India

*Corresponding Author: Shalini Verma, Radiation Oncology Department, Dr RPGMC, Tanda, Himachal Pradesh, India.

Received: October 23, 2020; Published: October 31, 2020



  The coronavirus pandemic has become global health emergency. This pandemic stage has brought great challenges to the diagnosis and management of Colorectal cancer (CRC). Surgery being the cornerstone of treatment is difficult to perform at this stage when there is so much burden on the limited hospital resources and social distancing is the only hope of staying protected from such contagious virus. Moreover cancer patients are highly susceptible to Covid-19 infection and treating cancer patients like before is associated with devastating complication with very poor outcome. At this stage healthcare providers should not emphasize only on therapeutics strategy but also on prevention from Covid-19. In this paper we have focused on the challenges pertaining to the screening, diagnosis and management of CRC and the best efforts that can to made to mitigate risks with the available resources.

Keywords: Covid-19; Colorectal Cancer (CRC); Coronavirus Disease



  1. Guan WJ., et al. “Clinical Characteristics of Coronovirus Disease 2019 in China”. The New England Journal of Medicine 382 (2020): 1708-1720.
  2. Guo YR., et al. “The Origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak –an update on the status”. Military Medical Research1 (2020): 11.
  3. Onder G., et al. “Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy”. JAMA18 (2020): 1775-1776.
  4. Wang L., et al. “Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition)”. Annals of Translational Medicine's 8 (2020): 47.
  5. Liang W., et al. “Cancerpatients in SARS-Cov-2 infection: A Nationwide analysis in China”. Lancet Oncology 21 (2020): 335-337.
  6. Yu J., et al. “SARS-Cov-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China”. JAMA Oncology7 (2020): 1108-1110.
  7. Saftoiu A., et al. “Role of gastriontesinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement”. Endoscopy 52 (2020): 293-304.
  8. Lee Y., et al. “Time to Colonoscopy and risk of Colorectal Cancer in patients with positive results from fecal immunochemical tests”. Clinical Gastroenterology and Hepatology 7 (2019): 1332-1340.
  9. Zhang H., et al. “The digestive system is a potential route of 2019-n Cov infection: a bioinformatics analysis based on single-cell transcriptomes”. bioRxiv (2020).
  10. Xu Y., et al. “Characteristics of pediatrics SARS-Cov-2 infection and potential evidence for persistant fecal viral shedding”. Nature Medicine 26 (2020): 502-505.
  11. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 395 (2020): 497-506.
  12. Gu J and Han J. “COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission”. Gastroenterology6 (2020): 1518-1519.
  13. Shi Q., et al. “Diagnosis and treatment of emergency digestive endoscopy in Zhongshan hospital of Fudan university during the outbreak of COVID-19”. Chinese Journal of Digestive Endoscopy 6 (2020): 805-808.
  14. Wang D., et al. “Clinical characteristics of 138 hospitalized pateints with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. JAMA11 (2020): 1061-1069.
  15. Zhang J., et al. “Clinical characteristics of 140 patients infected with SARS-Cov-2 in Wuhan, China”. Allergy7 (2020): 1730-1741.
  16. Lee JK., et al. “Accuracy of fecal immunohistochemical tests for colorectal cancer: systemic review and meta-analysis”. Annuals of Internal Medicine3 (2014): 171.
  17. Rabeneck L., et al. “International perspective on the burden of colorectal cancer and public health effects”. Gastroenterology2 (2020): 447-52.
  18. Mowat C., et al. “Fecal haemoglobin and fecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptom”. Gut 65 (2016): 1463-1469.
  19. Thiele RH., et al. “Standardization of Care Impact of Enhanced Recovery Protocol on Length of Stay, Complications, and Direct Costs after Colorectal Surgery”. Journal of the American College of Surgeons 220 (2015): 430-443.
  20. Bagaria SP., et al. “Delay to colectomy and survival for pateints diagnosed with colon cancer”. Journal of Investigation Surgery 32 (2019): 350-357.
  21. Hangard Hansen C., et al. “The effect of time from diagnosis to surgery on oncological outcomes in pateints undergoing surgery for colon cancer: a systematic review”. European Journal of Surgical Oncology 44 (2018): 1479-1485.
  22. Erlandsson J., et al. “Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non blinded, phase 3, non inferiority trial”. Lancet Oncology 18 (2017): 336-346.
  23. Van der Valk MJM., et al. “Compliance and tolerability of short- course radiotherapy followed by preopertaive chemotherapy and surgery high-risk rectal cancer-results of the international randomised RAPIDO-trial”. Radiotherapy Oncology 147 (2020): 75-83.
  24. Carvalho C and Glynne-Jones R. “Challenges behing proving efficacy of adjuvant chemotherapy after preopertaive chemoradiation for rectal cancer”. Lancet Oncology 18 (2017): 354-363.
  25. Liu F., et al. “CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial”. Chinese Journal of Cancer Research 28 (2016): 589-597.
  26. Timothy Iveson., et al. “Prospective pooled analysis of four randomised trials investigating duration of adjuvant oxaliplatin- based therapy (3 vs 6 months) for patients with high-risk stage II colorectal cancer”. Journal of Clinical Oncology 37 (2019): 3501.
  27. Chen YH., et al. “Treatment strategy for gastrointestinal tumour under the outbreak of novel coronavirus pneumonia in China”. Zhonghua Wei Chang Wai Ke Za Zhi 23 (2020): I-IV.


Citation: Shalini Verma., et al. “Challenges in Screening, Diagnosis and Management of Colorectal Cancers in Covid-19 Era". Acta Scientific Medical Sciences 4.11 (2020): 28-33.


Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US